Literature DB >> 9763146

Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner.

L Mosekilde1, J S Thomsen, P B Orhii, D N Kalu.   

Abstract

The aim of the study was to assess the effect of growth hormone (GH) as restorative therapy in an aged, ovariectomized rat model with established osteopenia. The study was planned as a dose-response study, and four different skeletal sites were investigated by mechanical testing and measurements of bone mass and dimensions. Twelve-month-old virgin F344 rats were divided into eight groups with ten animals per group: (1) sham operated (sham); (2) ovariectomized (ovx); (3) sham + solvent vehicle (sv); (4) ovx + sv; (5) ovx + GH 50 microg/kg body weight/day; (6) ovx + GH 1.25 mg/kg body weight/day; (7) ovx + GH 2.5 mg/kg body weight/day; and (8) ovx + GH 5.0 mg/kg body weight/day. Groups 1 and 2 were killed after 3 months to establish that bone loss had occurred due to ovx. One month later, the remaining groups began 3 months of treatment, at the end of which the animals were also killed. The effects of ovariectomy (ovx) and GH therapy were measured at four skeletal sites: lumbar vertebrae; femoral diaphysis; femoral neck; and distal femoral metaphysis. Ovariectomy induced a significant loss of bone strength at all sites apart from the femoral neck. The loss was most pronounced at the distal femoral metaphysis. GH was able to reverse the ovx-induced loss of strength at the vertebral site in a dose-dependent manner. At the femoral diaphyseal site, GH not only reversed the ovx-induced changes but increased load values significantly above sham level. However, at the distal femoral metaphysis, which is dominated by cancellous bone, only partial reversal was seen after GH treatment. The lowest GH dose had no significant effect at any site tested. We conclude that GH treatment can reestablish vertebral bone loss due to ovariectomy in a dose-dependent manner. The restorative effect is only partial at the distal femoral metaphysis even at a high dose. At skeletal sites with less pronounced ovx-induced bone loss (femoral neck and diaphysis), GH treatment increased bone strength to sham level or above sham level. Therefore, the effect of ovariectomy is dependent upon the skeletal site investigated, and the effect of GH treatment is dependent on both the skeletal site and the size of the ovx-induced bone loss at this site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763146     DOI: 10.1016/s8756-3282(98)00107-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  The relative importance of genetics and phenotypic plasticity in dictating bone morphology and mechanics in aged mice: evidence from an artificial selection experiment.

Authors:  Kevin M Middleton; Corinne E Shubin; Douglas C Moore; Patrick A Carter; Theodore Garland; Sharon M Swartz
Journal:  Zoology (Jena)       Date:  2008-01-24       Impact factor: 2.240

Review 2.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

3.  Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats.

Authors:  Francesco Cavani; Marzia Ferretti; Gianluca Carnevale; Laura Bertoni; Manuela Zavatti; Carla Palumbo
Journal:  J Bone Miner Metab       Date:  2012-07-25       Impact factor: 2.626

4.  Microarchitecture, but not bone mechanical properties, is rescued with growth hormone treatment in a mouse model of growth hormone deficiency.

Authors:  Erika Kristensen; Benedikt Hallgrímsson; Douglas W Morck; Steven K Boyd
Journal:  Int J Endocrinol       Date:  2012-03-13       Impact factor: 3.257

Review 5.  Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.

Authors:  Vittorio Locatelli; Vittorio E Bianchi
Journal:  Int J Endocrinol       Date:  2014-07-23       Impact factor: 3.257

6.  Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1).

Authors:  J Christopher Fritton; Kelly B Emerton; Hui Sun; Yuki Kawashima; Wilson Mejia; Yingjie Wu; Clifford J Rosen; David Panus; Mary Bouxsein; Robert J Majeska; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

7.  Global and site-specific analysis of bone in a rat model of spinal cord injury-induced osteoporosis.

Authors:  Jonathan A Williams; James F C Windmill; K Elizabeth Tanner; John S Riddell; Sylvie Coupaud
Journal:  Bone Rep       Date:  2019-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.